Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
Clinical trial NCT05305859 · RECRUITING
Trial details
- NCT number
- NCT05305859
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-12
- Primary completion
- 2026-01-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.